Germany supplies 37.1% of U.S. imports of Blood-Grouping Diagnostic Reagents and Kits, across 13 countries (year to date through September 2026).
HHI 2,443 of 10,000 · HHI above 1,800. The sum of each country’s squared percentage share; one country with everything scores 10,000.
13 countries supplying this product to the U.S.
| Rank# | Country | Value | Share | YoY | Duty |
|---|---|---|---|---|---|
| 1 | Germany | $1.2M | 36.1% | -10.8% | 10.0% |
| 2 | United Kingdom | $1.2M | 34.6% | -53.6% | 7.4% |
| 3 | Japan | $240K | 7.0% | +231.6% | 12.5% |
| 4 | France | $228K | 6.6% | -15.0% | 10.0% |
| 5 | Switzerland | $210K | 6.1% | -6.6% | 8.6% |
| 6 | Denmark | $202K | 5.9% | -0.2% | 10.0% |
| 7 | Israel | $91K | 2.7% | +5145.2% | 12.5% |
| 8 | Italy | $41K | 1.2% | -- | 10.0% |
| 9 | South Korea | -- | 0.0% | -96.9% | -- |
| 10 | Taiwan | -- | 0.0% | -97.3% | -- |
| 11 | Sweden | -- | 0.0% | -- | -- |
| 12 | Canada | -- | 0.0% | -89.2% | -- |
| 13 | China | -- | 0.0% | +13.5% | -- |
Duty is the duty Census calculated on this month's imports for consumption from each country, as a share of their customs value. It applies the rates in force, additional duties such as Section 301, 232 and IEEPA included and claimed trade-agreement preferences netted out, so it is an observed rate rather than a statutory one. It is an estimate, not duty collected: antidumping and countervailing duties, fees and later refunds are not in it. YoY compares year-to-date value with the same months last year.